Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 3

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(2)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06282042Not ApplicableRecruiting

Early Transcatheter Mitral Valve Repair After Myocardial Infarction

Role: lead

NCT06614595Recruiting

Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS

Role: lead

NCT05518786Unknown

Precision Medicine for Post-Intensive Care Syndrome (PreMed4PICS)

Role: lead

NCT04838938Completed

Personalized Medicine in Patients With Infective Endocarditis

Role: lead

NCT05311254Phase 3Unknown

A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia

Role: lead

NCT04915391Unknown

Restenosis in Coronary Stents And Cutaneous HEaLing

Role: lead

NCT04660448Completed

Lung Ultrasound Score and Pediatric Intensive Care Outcomes (LUS-PICO)

Role: lead

NCT03041428Not ApplicableCompleted

Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO)

Role: lead

NCT04552951Phase 4Unknown

Effect of Vitamin D on Morbidity and Mortality of the COVID-19

Role: lead

NCT03464929Completed

Learning Curves for Airtraq Versus King Vision Laryngoscopes

Role: lead

All 10 trials loaded